Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

634 ARTÍCULOS , VIENDO DEL 556 AL 570

PACAP: A promising disease-modifying target for Alzheimer's disease

Basri R, Al-Kuraishy HM, Fawzy MN, Alruwaili M, Batiha GE.

Life Sci. 2026 Feb 1;386:124176. doi: 10.1016/j.lfs.2025.124176. Epub 2025 Dec 24.

Emerging therapeutics targeting the PI3K/Akt/GSK-3β in calcium dysregulation in Alzheimer's disease

Soni S, Kaur G.

Cell Calcium. 2026 Jan;133:103107. doi: 10.1016/j.ceca.2025.103107. Epub 2025 Dec 23.

Metal-Organic Frameworks as Interfacial Platforms for Early Diagnosis of Alzheimer's Disease

Thokal G, Garg M, Bathinapatla A, Farale H, Kanchi S.

Langmuir. 2026 Jan 13;42(1):32-56. doi: 10.1021/acs.langmuir.5c04804. Epub 2025 Dec 29.

Precision therapeutic strategies for Alzheimer's disease: Amyloid β-targeted foundations and multimodal next-generation approaches

Zafar I, Khan MS, Jamal A, Shafiq S, Bahwerth FS, Khan NU.

Mol Cell Neurosci. 2026 Mar;136:104070. doi: 10.1016/j.mcn.2025.104070. Epub 2025 Dec 30.

Natural glycosides as multi-target neuroprotective agents in Alzheimer's disease: Bridging mechanistic insights and translational potential

Zhou M, Tang S, Zhang Y, Fu G, Yu W, Wang S, Cheng S, Song Z.

Phytomedicine. 2026 Jan;150:157738. doi: 10.1016/j.phymed.2025.157738. Epub 2025 Dec 23.

Alzheimer's disease: unraveling role of xanthone derivatives and nanocarriers

Suhaili INA, Yow HY, Mah SH, Zaman Huri H, Tan SLJ.

Naunyn Schmiedebergs Arch Pharmacol. 2026 Jan;399(1):1-17. doi: 10.1007/s00210-025-04446-8. Epub 2025 Aug 1.

Genetic and functional dynamics of Butyrylcholinesterase in Alzheimer's disease: From mechanisms to clinical relevance

Prešern U, Goličnik M, Bavec A.

Chem Biol Interact. 2026 Jan 5;423:111809. doi: 10.1016/j.cbi.2025.111809. Epub 2025 Nov 5.

The association of the Wnt/β-catenin signaling pathway with Alzheimer's disease

Ma J, Liu Y, Lu D, Sun Q.

Neuropharmacology. 2026 Feb 1;283:110754. doi: 10.1016/j.neuropharm.2025.110754. Epub 2025 Nov 6.

Natural alkaloids with therapeutic potential against Alzheimer's disease through cholinesterase inhibition

Khan U, Ahmad M, Tuba M, Naaz R, Qayum F, Khatoon S, Sanobar, Ahamad S, Saquib M, Hussain MK.

Eur J Med Chem. 2026 Jan 15;302(Pt 2):118371. doi: 10.1016/j.ejmech.2025.118371. Epub 2025 Nov 12.

The mtDNA-ZBP1 axis in alzheimer's disease: Mechanisms, pathogenesis, and therapeutic implications

Chen Y, Liu Y, Hu H, Li S.

Int Immunopharmacol. 2026 Jan 1;168(Pt 1):115853. doi: 10.1016/j.intimp.2025.115853. Epub 2025 Nov 18.

Serotonin-mediated regulation of mitophagy in Alzheimer's disease: Mechanistic insights and therapeutic potential

Sultana OF, Bandaru M, Bushra MA, Reddy PH, Reddy AP.

Ageing Res Rev. 2026 Jan;114:102957. doi: 10.1016/j.arr.2025.102957. Epub 2025 Nov 25.

Neurobiotech innovative strategies targeting Alzheimer's disease through therapeutic micro and macroalgae potentials

Wagdy M, Ibrahim AA, Yahia AM, Maher RM, Abo-Elwafa AH, Salah A, Heikal YM.

J Neuroimmunol. 2026 Feb;411:578821. doi: 10.1016/j.jneuroim.2025.578821. Epub 2025 Nov 25.

Decoding senescent drivers in Alzheimer's disease: From bench to bedside

Zhou R, Lin X, Liao Z, Lin J, Zheng R, Ni H, Liu W, Feng Z, He Q, Lin X, Tang C, Song J, Ning W.

Ageing Res Rev. 2026 Jan;114:102978. doi: 10.1016/j.arr.2025.102978. Epub 2025 Dec 2.

Assessing the critical role of ceramide in the pathogenesis of Alzheimer's disease and its clinical significance

Huang YW, Chan HC, Khoo JY, Chan ML, Bender D, Ponnusamy VK, Belaidi AA, Ke LY.

Neurochem Int. 2026 Jan;192:106104. doi: 10.1016/j.neuint.2025.106104. Epub 2025 Dec 14.

Antioxidants as immunomodulators for Tau and Amyloid-β in Alzheimer's disease

Chinnathambi S, Rangappa N, Chandrashekar M.

Adv Protein Chem Struct Biol. 2026;151:303-365. doi: 10.1016/bs.apcsb.2025.10.007. Epub 2025 Nov 7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias